Cytokinetics | CYTK - Trade Debtors


Cytokinetics reported $6.83M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Amgen USD 9.14B 432M Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Brainstorm Cell Therapeutics USD 86K 6K Dec/2025
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Capricor Therapeutics USD 59K 0 Dec/2025
Cytokinetics USD 6.83M 10.94M Mar/2026
Eisai JPY 227B 22.05B Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Exelixis USD 328.95M 42.03M Mar/2026
Geron USD 39.23M 1.57M Dec/2025
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026